Assets for Entrepreneurial Success

Sofinnova Ventures has over 30 years of experience building start-ups and spin-outs into market leaders. With $1 billion under management, the firm applies capital and expertise to guide early stage companies to successful exits.

About Us

Learn about our team, investments, and approach

People | Portfolio | Perspective

Portfolio News

February 23, 2010 Intellikine Appoints William Rohn to Its Board of Directors
February 23, 2010 Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
February 08, 2010 Anthera Pharmaceuticals Announces Agreement with the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
February 08, 2010 InteKrin Therapeutics' Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
January 27, 2010 Movetis launches Resolor® in Germany

Contact

Contact information for our offices in Menlo Park, San Francisco, and San Diego.

For information about our sister firm Sofinnova Partners based in Paris, France, please visit www.sofinnova.fr.